Claire Mazumdar

Chief Executive Officer at Bicara Therapeutics Inc.

Sits on 2 boards. Last updated September 28, 2026

Time on boards

Boards served
2
Current seats
2
Board service
4 years
Director since
2024

4 years of board service in total across 2 boards, counting each seat separately. Longest: Bicara Therapeutics Inc., 2 years.

Bicara Therapeutics Inc. Director · Chief Executive Officer
2 years · Since 2024
1 year · Since 2025

Chief executive roles

Bicara Therapeutics Inc. · Chief Executive Officer
Since September 2024

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Aug 10, 2026 Bicara Therapeutics Inc. Option exercise +10,000 $3.79 $37,900
Aug 10, 2026 Bicara Therapeutics Inc. Open-market sale −10,000 $27.98 $279,800
Jul 10, 2026 Bicara Therapeutics Inc. Option exercise +10,000 $3.79 $37,900
Jul 10, 2026 Bicara Therapeutics Inc. Open-market sale −9,972 $28.42 $283,404
Jul 10, 2026 Bicara Therapeutics Inc. Open-market sale −28 $29.68 $831
May 18, 2026 Bicara Therapeutics Inc. Option exercise +15,000 $3.79 $56,850
May 18, 2026 Bicara Therapeutics Inc. Open-market sale −12,022 $19.96 $239,959
May 18, 2026 Bicara Therapeutics Inc. Open-market sale −2,978 $20.35 $60,602
Apr 20, 2026 Bicara Therapeutics Inc. Option exercise +15,000 $3.79 $56,850
Apr 20, 2026 Bicara Therapeutics Inc. Open-market sale −15,000 $23.61 $354,150
Apr 16, 2026 Bicara Therapeutics Inc. Option exercise +8,226 $4.44 $36,523
Apr 16, 2026 Bicara Therapeutics Inc. Option exercise +7,454 $3.79 $28,251
Apr 16, 2026 Bicara Therapeutics Inc. Option exercise +7,080 $5.45 $38,586
Mar 20, 2026 Bicara Therapeutics Inc. Option exercise +1,596 $3.79 $6,049
Mar 20, 2026 Bicara Therapeutics Inc. Open-market sale −1,596 $18.95 $30,244

Questions about Claire Mazumdar

What boards is Claire Mazumdar on?

Claire Mazumdar sits on the boards of Bicara Therapeutics Inc. and Relay Therapeutics Inc.

What company is Claire Mazumdar the CEO of?

Claire Mazumdar has been Chief Executive Officer of Bicara Therapeutics Inc. since September 2024.

How long has Claire Mazumdar served on boards?

Our records show at least 4 years of board service across 2 boards, the earliest from 2024.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.